205 related articles for article (PubMed ID: 25896364)
1. Gene expression profiling identifies the novel role of immunoproteasome in doxorubicin-induced cardiotoxicity.
Zhao WJ; Wei SN; Zeng XJ; Xia YL; Du J; Li HH
Toxicology; 2015 Jul; 333():76-88. PubMed ID: 25896364
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial ROS-induced ERK1/2 activation and HSF2-mediated AT
Huang CY; Chen JY; Kuo CH; Pai PY; Ho TJ; Chen TS; Tsai FJ; Padma VV; Kuo WW; Huang CY
J Cell Physiol; 2018 Jan; 233(1):463-475. PubMed ID: 28295305
[TBL] [Abstract][Full Text] [Related]
3. Microarray and Co-expression Network Analysis of Genes Associated with Acute Doxorubicin Cardiomyopathy in Mice.
Wei SN; Zhao WJ; Zeng XJ; Kang YM; Du J; Li HH
Cardiovasc Toxicol; 2015 Oct; 15(4):377-93. PubMed ID: 25575753
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of chymotryptic-like standard proteasome activity exacerbates doxorubicin-induced cytotoxicity in primary cardiomyocytes.
Spur EM; Althof N; Respondek D; Klingel K; Heuser A; Overkleeft HS; Voigt A
Toxicology; 2016 Apr; 353-354():34-47. PubMed ID: 27155237
[TBL] [Abstract][Full Text] [Related]
5. Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin.
Wang Y; Zheng D; Wei M; Ma J; Yu Y; Chen R; Lacefield JC; Xu H; Peng T
Cardiovasc Res; 2013 Jun; 98(3):381-90. PubMed ID: 23455548
[TBL] [Abstract][Full Text] [Related]
6. Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins.
Bian Y; Sun M; Silver M; Ho KK; Marchionni MA; Caggiano AO; Stone JR; Amende I; Hampton TG; Morgan JP; Yan X
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H1974-83. PubMed ID: 19801490
[TBL] [Abstract][Full Text] [Related]
7. TRIM25 Rescues Against Doxorubicin-Induced Pyroptosis Through Promoting NLRP1 Ubiquitination.
Wang X; Lian Z; Ge Y; Yu D; Li S; Tan K
Cardiovasc Toxicol; 2021 Oct; 21(10):859-868. PubMed ID: 34313957
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
[TBL] [Abstract][Full Text] [Related]
9. HECT-Type Ubiquitin E3 Ligase ITCH Interacts With Thioredoxin-Interacting Protein and Ameliorates Reactive Oxygen Species-Induced Cardiotoxicity.
Otaki Y; Takahashi H; Watanabe T; Funayama A; Netsu S; Honda Y; Narumi T; Kadowaki S; Hasegawa H; Honda S; Arimoto T; Shishido T; Miyamoto T; Kamata H; Nakajima O; Kubota I
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26796253
[TBL] [Abstract][Full Text] [Related]
10. Early biomarkers of doxorubicin-induced heart injury in a mouse model.
Desai VG; C Kwekel J; Vijay V; Moland CL; Herman EH; Lee T; Han T; Lewis SM; Davis KJ; Muskhelishvili L; Kerr S; Fuscoe JC
Toxicol Appl Pharmacol; 2014 Dec; 281(2):221-9. PubMed ID: 25448438
[TBL] [Abstract][Full Text] [Related]
11. Role of HMGB1 in doxorubicin-induced myocardial apoptosis and its regulation pathway.
Yao Y; Xu X; Zhang G; Zhang Y; Qian W; Rui T
Basic Res Cardiol; 2012 May; 107(3):267. PubMed ID: 22527657
[TBL] [Abstract][Full Text] [Related]
12. A therapeutic dose of doxorubicin activates ubiquitin-proteasome system-mediated proteolysis by acting on both the ubiquitination apparatus and proteasome.
Liu J; Zheng H; Tang M; Ryu YC; Wang X
Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2541-50. PubMed ID: 18978187
[TBL] [Abstract][Full Text] [Related]
13. Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway.
Horie T; Ono K; Nishi H; Nagao K; Kinoshita M; Watanabe S; Kuwabara Y; Nakashima Y; Takanabe-Mori R; Nishi E; Hasegawa K; Kita T; Kimura T
Cardiovasc Res; 2010 Sep; 87(4):656-64. PubMed ID: 20495188
[TBL] [Abstract][Full Text] [Related]
14. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte.
Wan GX; Cheng L; Qin HL; Zhang YZ; Wang LY; Zhang YG
Cardiovasc Toxicol; 2019 Jun; 19(3):264-275. PubMed ID: 30535663
[TBL] [Abstract][Full Text] [Related]
15. Multi-walled carbon nanotubes exacerbate doxorubicin-induced cardiotoxicity by altering gut microbiota and pulmonary and colonic macrophage phenotype in mice.
Liu X; Liu Y; Chen X; Wang C; Chen X; Liu W; Huang K; Chen H; Yang J
Toxicology; 2020 Apr; 435():152410. PubMed ID: 32068018
[TBL] [Abstract][Full Text] [Related]
16. Sex-related differences in delayed doxorubicin-induced cardiac dysfunction in C57BL/6 mice.
Abdelgawad IY; George B; Grant MKO; Huang Y; Shan Y; Huang RS; Zordoky BN
Arch Toxicol; 2024 Apr; 98(4):1191-1208. PubMed ID: 38244039
[TBL] [Abstract][Full Text] [Related]
17. MiR-200a-3p Aggravates DOX-Induced Cardiotoxicity by Targeting PEG3 Through SIRT1/NF-κB Signal Pathway.
Fu Q; Pan H; Tang Y; Rong J; Zheng Z
Cardiovasc Toxicol; 2021 Apr; 21(4):302-313. PubMed ID: 33638775
[TBL] [Abstract][Full Text] [Related]
18. Loss of Mrp1 Potentiates Doxorubicin-Induced Cytotoxicity in Neonatal Mouse Cardiomyocytes and Cardiac Fibroblasts.
Zhang W; St Clair D; Butterfield A; Vore M
Toxicol Sci; 2016 May; 151(1):44-56. PubMed ID: 26822305
[TBL] [Abstract][Full Text] [Related]
19. Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity.
Ferreira A; Cunha-Oliveira T; Simões RF; Carvalho FS; Burgeiro A; Nordgren K; Wallace KB; Oliveira PJ
Toxicology; 2017 Sep; 390():63-73. PubMed ID: 28865727
[TBL] [Abstract][Full Text] [Related]
20. Protection against doxorubicin-induced myocardial dysfunction in mice by cardiac-specific expression of carboxyl terminus of hsp70-interacting protein.
Wang L; Zhang TP; Zhang Y; Bi HL; Guan XM; Wang HX; Wang X; Du J; Xia YL; Li HH
Sci Rep; 2016 Jun; 6():28399. PubMed ID: 27323684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]